支气管哮喘患者富半胱氨酸蛋白61与炎症因子表达水平的相关性被引量：2

下载PDF

导出

摘要支气管哮喘是常见的呼吸系统疾病之一，其患病率在世界范围内有逐渐增加的趋势。支气管哮喘是由多种炎性细胞和炎症因子参与的气道慢性炎症性疾病。

作者田琳娟刘巍吴允萍王东曹明嫄薛守斌张东岳周之贺

机构地区兰州市第一人民医院呼吸科

出处《临床荟萃》 CAS 2015年第8期940-942,共3页 Clinical Focus

关键词哮喘富含半胱氨酸蛋白质61 炎症因子

分类号 R562.25 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献14

1Emre Y, Imhof BA. Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking [J]. Semin Immunopathol, 2014, 36(2)~ 253-259.
2Dhar A, Ray A. The CCN family proteins in carcinogenesis [J]. Exp Oncol, 2010, 32(1): 2-9.
3Lau LF. CCN1/CYR61: the very model of a modern matricellular protein E J 1. Cell Mol Life Sci, 2011, 68 ( 19 ) .- 3149-3163.
4支气管哮喘防治指南（支气管哮喘的定义、诊断、治疗和管理方案）[J].中华结核和呼吸杂志,2008,31(3):177-185. 被引量：2525
5Shen H, Cai M, Zhao S, et al. CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma[J]. Med Oncol, 2014, 31(8) : 117.
6Cheng G, Zhang H, Zhang L, et al. Cyr61 promotes growth of gliohlastoma in vitro and in vivo[J]. Tumour Biol, 2015, 36 (4) : 2869-2873.
7Jeong D, Heo S, Sung Ahn T, et al. Cyr61 expression is associated with prognosis inpatients with eoloreetal caneer[J]. BMC Cancer, 2014, 14: 164.
8Chien W, Kumagai T, Miller CW, et al. Cyr61 suppresses growth of human endometria[ cancer cells[J]. J Biol Chem, 2004, 279(51)~ 53087 53096.
9曹勇,陈辉龙,方慧娟.富半胱氨酸61在哮喘小鼠气道上皮细胞中表达的研究[J].医药导报,2013,32(10):1274-1277. 被引量：2
10庞怀刚,高丽.CRP、TNF-α、PCT及T淋巴细胞亚群在老年哮喘急性发作期中的应用价值分析[J].中国实验诊断学,2013,17(12):2195-2198. 被引量：7

二级参考文献65

1Hskon H, Maskeri N, Cartel C, et al. Regulation of Thl - and 2 - type eytokine expression and action in atopic sensitized air - way smooth muscle[ J]. Jain Invest, 1999,103 : 1 077.
2Kunz M, Moeller S, Koczan D et al. Mechanisms of hypoxic gene regulation of angiogenesis factor Cyt61 in melanoma cells [ J]. J Biol Chem, 2003 ; 278 (46) : 45651-45660.
3Xie D, Yin D, Wang H J et al. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas[J]. Clin Cancer Res,2004; 10 (6) :2072-2081.
4Tong X, O' Kelly J, Xie D et al. Cyr61 suppresses the growth of non- small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway[ J]. Oncogene,2004;23 (28) :4847-4855.
5Grzeszkiewicz T M, Kirschling D J, Chen N et al. CYR61 stimulates human skin fibroblast migration lhrough Integrin "alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain[J]. J Biol Chem,2001 ;276 (24):21943-21950.
6Chen N, Chen C C, Lau L F. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans[J] .J Biol Chem,2000;275 (32) :24953-24961.
7Holloway S E, Beck A W, Girard L et al. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer [J] .J Am Coll Surg,2005;200 (3):371-377.
8Sampath D, Zhu Y, Winneker R C et al. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas[J] .J Clin Endocrinol Metab,2001 ;86 (4):1707-1715.
9Arnett F C, Edworthy S M, Bloch D A et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum, 1988;31 (3) :315-324.
10Altman R, Asch E, Bloch D et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American Rheumatism Association[J]. Arrthritis Rheum, 1986;29 (8) : 1039-1049.